ARES-SERONO, the leader in human fertility drugs, said its net income from
operations in the first quarter jumped 25 per cent to Dollars 16.6m.
Sales gained 15.5 per cent to Dollars 198m and operating income was up 18.3
per cent to Dollars 38.1m. Net income after the extraordinary gain on the
sale of the group's over-the-counter division to American Home Products in
March was Dollars 44.7m, or Dollars 82.20 per share, compared with Dollars
13.5m or Dollars 24.76 per share.
